Biotech

Biotechnology, gene editing, biopharma platforms, and clinical pipelines.

  • 9 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Biotech


deloitte.com > us > en > about > press-room > deloitte-launches-fastforward-for-life-sciences.html

Deloitte Launches Fastforward for Life Sciences – Press Release

3+ hour, 7+ min ago   (455+ words) Deloitte If we have selected the wrong experience for you, please change it above. Deloitte Launches FastForward™ for Life Sciences, an Agentforce-Powered Customer Relationship Management Accelerator Offering is designed to enhance time to value, provide a predictable cost model and…...


contractpharma.com > breaking-news > evonik-breaks-ground-on-new-biotechnology-expansion-project-in-slovakia

Evonik Breaks Ground on New Biotechnology Expansion Project in Slovakia

6+ hour, 24+ min ago   (227+ words) The project is slated for completion in 2028 and will create approximately 50 new jobs. Evonik broke ground on a new biotechnology expansion project at its Fermas site, located in Slovenská Ľupča, Slovakia. The company says the groundbreaking is the next major…...


midfloridanewspapers.com > ap > business > aptar-pharma-and-massachusetts-general-hospital-collaborate-on-platform-to-establish-predictive-data-driven-model > article_03cb39e5-28eb-500e-8451-4e8bb5029823.html

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

2+ hour, 52+ min ago   (184+ words) AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH)…...


eastsidefeed.com > real-estate > the-sign-on-east-94th-street-still-promises-a-lab-by-summer-2025-the-site-just-sold-instead

This Sign on East 94th Street Still Promises a Lab by Summer 2025. The Site Just Sold Instead.

6+ hour, 40+ min ago   (342+ words) East Side Feed Three and a half years ago, a developer announced a 200,000-square-foot research lab for the East 90s, complete with a rendering, a name honoring the Yankees legend who was born on the block, and a promise that it’d…...


prnewswire.com > apac > news-releases > taiwans-biotech-power-couple-kao-min-min-and-liao-po-yu-reveal-their-expanding-business-portfolio-across-health-and-lifestyle-industries-302877605.html

Taiwan's "Biotech Power Couple" Kao Min-Min and Liao Po-Yu Reveal Their Expanding Business Portfolio Across Health and Lifestyle Industries

11+ hour, 39+ min ago   (913+ words) 14 Sep, 2026, 20:13 CST TAIPEI, Sept. 14, 2026 /PRNewswire/ -- When people hear the name Kao Min-Min, many immediately think of the celebrity nutritionist and health expert who has built a strong professional presence across social media and digital content, reaching an audience of more…...


startupticker.ch > en > news > ingredients-innovator-ferm-labs-secures-3m

Ingredients innovator Ferm Labs secures €3M

8+ hour, 6+ min ago   (221+ words) One year following its incorporation, Swiss-Italian startup Ferm Labs AG has announced the closing of a €3M funding round. The capital will be used to scale the company’s bioprocessing platform which enables the production of saltless, clean‑label flavour enhancers for…...


indexbox.io > blog > topical-wound-dressing-market-to-accelerate-through-2035-driven-by-aging-demographics-and-chronic-wound-prevalence

Topical Wound Dressing Market Forecast to 2035: Aging Demographics and Chronic Wounds to Drive Growth - News and Statistics

1+ hour, 11+ min ago   (625+ words) According to the latest IndexBox report on the global Topical Wound Dressing market, the market enters 2026 with broader demand fundamentals, more disciplined procurement behavior, and a more regionally diversified supply architecture. This report provides a comprehensive analysis of market size,…...


tradingview.com > news > urn:summary_document_transcript:quartr.com:4167922:0-nvcr-growth-in-oncology-franchises-and-global-expansion-drive-profitability-and-pipeline-momentum

NVCR: Growth in oncology franchises and global expansion drive profitability and pipeline momentum

3+ hour, 23+ min ago   (71+ words) tradingview.com NVCR: Growth in oncology franchises and global expansion drive profitability and pipeline momentum Disciplined investment and cost controls have reignited GBM growth and enabled global expansion, with strong launches in pancreatic and lung cancer, especially in Japan. Profitability…...


thepharmaletter.com > pharma-news > sanofi-and-cheplapharm-to-create-new-partnership-in-mature-medicines

Sanofi and Cheplapharm to create new partnership in mature medicines

8+ hour, 23+ min ago   (225+ words) The Pharma Letter - Sanofi and Cheplapharm to create new partnership in mature medicines French pharma major Sanofi (Euronext; SAN) and Cheplapharm, a European leader in well-established medicines, today announced their intention to create a strategic partnership under which Cheplapharm would…...


contractpharma.com > breaking-news > shennonbio-names-cyril-konto-ceo-after-12m-raise

ShennonBio Names Cyril Konto CEO After $12M Raise

10+ hour, 46+ min ago   (113+ words) Cyril Konto brings more than 20 years of oncology drug development experience. Founder and current CEO Li Sun, Ph.D., will transition to President and Chief Technology Officer, continuing to lead the Company’s scientific strategy, technology development and pipeline innovation. Konto brings…...